The roles of APOBEC3B in gastric cancer.
Authors:
- 1 May 2015
- journal article
- Vol. 8 (5) , 5089-96
Abstract
Gastric cancer was the third cause of death in China. In this study, we found that the APOBEC3 (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3) expression was higher in gastric cancer tissues than that in normal tissues and confirmed APOBEC3B expression was correlated with the unfavorable prognosis of the patients with gastric cancer. Furthermore, APOBEC3B expression was associated with gender, tumor size, histological grade, T stage, and TNM staging of the patients with gastric cancer. Down-regulation of APOBEC3B expression in MNK28 cells could enhance the cytotoxicity of PDCD2. No editing took place in PDCD2 positive MKN28 cells with APOBEC3B shRNA. These results indicated that loss of function of PDCD2 may be partly caused by APOBEC3B-induced extensive mutagenesis.Keywords
This publication has 12 references indexed in Scilit:
- The role of APOBEC3B in chondrosarcomaOncology Reports, 2014
- Interleukin 16 expression changes in association with ovarian malignant transformationAmerican Journal of Obstetrics and Gynecology, 2014
- Annual report on status of cancer in China, 20102014
- DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivityMolecular Oncology, 2013
- Evidence for APOBEC3B mutagenesis in multiple human cancersNature Genetics, 2013
- The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral InfectionsBioMed Research International, 2013
- APOBEC3B is an enzymatic source of mutation in breast cancerNature, 2013
- Intrinsic immunity against retrotransposons by APOBEC cytidine deaminasesFrontiers in Microbiology, 2013
- The AID/APOBEC family of nucleic acid mutatorsGenome Biology, 2008
- Purification and DNA binding properties of the ataxia-telangiectasia gene product ATMProceedings of the National Academy of Sciences, 1999